• Navigation
  • Content
  • Footer
  • English
    • Français
  • Canada
    • Novartis Site Directory
Search
Novartis logo
  • Our Work
    • Our Process
    • Clinical Trials
    • Clinical Pipeline
    • Product Portfolio
  • About Us
    • Who We Are
    • Our Business
    • Corporate Responsibility
    • Contact Us
    • AODA Compliant
    • Grants and Donations
    • AMA Compliant
  • Our Products
    • Pharmaceuticals
    • Health Care Professional
    • For Consumers
  • News
    • Media Releases
    • Media Contacts
    • Stories
    • FAQ
  • Careers
    • Careers Search
    • Working at Novartis
    • Employee Benefits
    • Student Programs

News Archive

The content below is specific to Novartis Canada. To see all Novartis content, please visit the Novartis Global site.

Advanced SearchBasic Search
2018

May

Media Release / May 30, 2018

Novartis Canada celebrates annual Community Partnership Day across the country

Read More
Media Release / May 02, 2018

Health Canada approves KISQALI(TM) for the treatment of HR-positive and HER2-negative metastatic breast cancer in postmenopausal women in combination with letrozole as an initial endocrine-based therapy

Read More

February

Media Release / Feb 12, 2018

Novartis launches new awareness campaign for metastatic breast cancer community

Read More
2017

December

Media Release / Dec 05, 2017

Health Canada approves Rydapt(TM) (midostaurin), first targeted therapy for common form of acute myeloid leukemia (AML)

Read More

November

Media Release / Nov 30, 2017

Phase III STRIVE study data for erenumab (AMG334) in migraine prevention published in The New England Journal of Medicine

Read More

October

Media Release / Oct 30, 2017

Novartis releases results of first controlled, randomized clinical trial specifically designed for pediatric multiple sclerosis (MS)

Read More

September

Media Release / Sep 26, 2017

Ride for Life: Novartis employees embark on a 600-km bike ride for breast cancer

Read More
Media Release / Sep 13, 2017

Cosentyx® demonstrates sustained results in psoriasis with 5-year Phase III data

Read More

June

Media Release / Jun 22, 2017

Psoriasis bodypainting campaign puts dermatologists ‘in their patients’ shoes’

Read More
Media Release / Jun 22, 2017

Top 10 Novartis Facts and Figures

Read More

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • next ›
  • last »
    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • Pinterest
      • LinkedIn
      • Google +
      • Email

You are here

  1. Home ›
  2. News

Novartis Canada

  • Our Work
  • About Us
  • Our Products
  • News
  • Careers
  • Contact Us
  • Locations

Subscribe to Novartis

  • Twitter
  • Novartis Site Directory
© 2019 Novartis Pharmaceuticals Canada inc
  • Terms of Use
  • Privacy Policy
  • About Cookies

This site is intended for an audience in Canada.